Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
benevolentai
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
europe
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
tc
vertex pharmaceuticals
What
data
2
×
drug
2
×
early
2
×
medicines
accelerate
accelerating
achieve
actually
ago
astrazeneca
benevolentai
biotechs
clinical
collaboration
company
considering
development
discovery
diseases
dyne
expected
experimental
eyes
facili
focuses
founded
genetic
having
humans
ipo
ipos
journey
late
long
look
means
million
muscle
raised
rare
Language
unset
Current search:
early
×
data
×
drug
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
5 years ago
BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery
